The Most Recent Insights into the Roots of Gastric Cancer
暂无分享,去创建一个
[1] F. Roviello,et al. Postbiotics in oncology: science or science fiction? , 2023, Frontiers in microbiology.
[2] Meiqin Yan,et al. Circulating Proteins and Metabolite Biomarkers in Gastric Cancer: A Systematic Review and Meta-analysis. , 2023, Archives of medical research.
[3] Jiayu Wang,et al. Up-regulation of microRNA-183 reduces FOXO1 expression in gastric cancer patients with Helicobacter pylori infection. , 2023, Histology and histopathology.
[4] C. Mărginean,et al. Worldwide Prevalence and Risk Factors of Helicobacter pylori Infection in Children , 2022, Children.
[5] S. Ding,et al. Gastric mucosal precancerous lesions in Helicobacter pylori-infected pediatric patients in central China: A single-center, retrospective investigation , 2022, World journal of gastroenterology.
[6] C. Mărginean,et al. Old and New Aspects of H. pylori-Associated Inflammation and Gastric Cancer , 2022, Children.
[7] M. Keikha,et al. Clinical relevance of the cagA and vacA s1m1 status and antibiotic resistance in Helicobacter pylori: a systematic review and meta-analysis , 2022, BMC Infectious Diseases.
[8] T. Attard,et al. Gastric cancer in the pediatric population, a multicenter cross-sectional analysis of presentation and coexisting comorbidities , 2022, Journal of Cancer Research and Clinical Oncology.
[9] Hsiao‐Bai Yang,et al. Atrophic gastritis in Helicobacter pylori‐infected children , 2022, Helicobacter.
[10] A. Belmouden,et al. Potential Non-invasive Biomarkers of Helicobacter pylori-Associated Gastric Cancer , 2021, Journal of Gastrointestinal Cancer.
[11] Hyunsoon Cho,et al. Influence of Fasting Glucose Level on Gastric Cancer Incidence in a Prospective Cohort Study , 2021, Cancer Epidemiology, Biomarkers & Prevention.
[12] A. Lagomarcino,et al. Effect of Helicobacter pylori eradication therapy on clinical and laboratory biomarkers associated with gastric damage in healthy school‐aged children: A randomized non‐blinded trial , 2021, Helicobacter.
[13] Alina Boglis,et al. Innate immunity – the hallmark of Helicobacter pylori infection in pediatric chronic gastritis , 2021, World journal of clinical cases.
[14] C. Mărginean,et al. Gastric Microenvironment—A Partnership between Innate Immunity and Gastric Microbiota Tricks Helicobacter pylori , 2021, Journal of clinical medicine.
[15] F. Chu,et al. Serum pepsinogen II levels are doubled with Helicobacter pylori infection in an asymptomatic population of 40,383 Chinese subjects , 2021, Medicine.
[16] Wenling Chen,et al. Application of serum pepsinogen and carbohydrate antigen 72-4 (CA72-4) combined with gastrin-17 (G-17) detection in the screening, diagnosis, and evaluation of early gastric cancer. , 2021, Journal of gastrointestinal oncology.
[17] T. Daniluk,et al. Nanomechanical Hallmarks of Helicobacter pylori Infection in Pediatric Patients , 2021, International journal of molecular sciences.
[18] J. Hasty,et al. The microbiome and human cancer , 2021, Science.
[19] L. Meliț,et al. MicroRNA Modulation of Host Immune Response and Inflammation Triggered by Helicobacter pylori , 2021, International journal of molecular sciences.
[20] M. Mahmoud,et al. Human apoptosis antibody array-membranes studying the apoptotic effect of marine bacterial exopolysaccharides in HepG2 cells , 2021, Journal of cancer research and therapeutics.
[21] A. Lagomarcino,et al. Helicobacter pylori, clinical, laboratory and noninvasive biomarkers suggestive of gastric damage in healthy school-aged children: a case-control study. , 2020, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[22] Ming-Wei Lin,et al. NF-κB/miR-18a-3p and miR-4286/BZRAP1 axis may mediate carcinogenesis in Helicobacter pylori-Associated gastric cancer. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[23] Nayoung Kim,et al. Promising aberrant DNA methylation marker to predict gastric cancer development in individuals with family history and long-term effects of H. pylori eradication on DNA methylation , 2020, Gastric Cancer.
[24] Qiong Wu,et al. Recent advances of miRNAs in the development and clinical application of gastric cancer , 2020, Chinese medical journal.
[25] J. Machlowska,et al. Gastric Cancer: Epidemiology, Risk Factors, Classification, Genomic Characteristics and Treatment Strategies , 2020, International journal of molecular sciences.
[26] L. Kupčinskas,et al. Transient and Persistent Gastric Microbiome: Adherence of Bacteria in Gastric Cancer and Dyspeptic Patient Biopsies after Washing , 2020, Journal of clinical medicine.
[27] R. Artigiani,et al. The impact of DNA demethylation on the upregulation of the NRN1 and TNFAIP3 genes associated with advanced gastric cancer , 2020, Journal of Molecular Medicine.
[28] W. El-Rifai,et al. Bacterial CagA protein compromises tumor suppressor mechanisms in gastric epithelial cells. , 2020, The Journal of clinical investigation.
[29] Yingwei Xue,et al. Relationship between DLEC1 and PBX3 promoter methylation and the risk and prognosis of gastric cancer in peripheral blood leukocytes , 2020, Journal of Cancer Research and Clinical Oncology.
[30] Meilin Wang,et al. MUC1 is associated with TFF2 methylation in gastric cancer , 2020, Clinical Epigenetics.
[31] A. Lagomarcino,et al. Gastric Damage and Cancer-Associated Biomarkers in Helicobacter pylori-Infected Children , 2020, Frontiers in Microbiology.
[32] Chaomin Wan,et al. The relationship of gastric microbiota and Helicobacter pylori infection in pediatrics population , 2019, Helicobacter.
[33] A. Szaflarska-Popławska,et al. Relationship between Helicobacter pylori Infection and Plasmacytoid and Myeloid Dendritic Cells in Peripheral Blood and Gastric Mucosa of Children , 2019, Mediators of inflammation.
[34] Ting Zhang,et al. SIRT1-targeted miR-543 autophagy inhibition and epithelial–mesenchymal transition promotion in Helicobacter pylori CagA-associated gastric cancer , 2019, Cell Death & Disease.
[35] Zhenhua Zhu,et al. The eradication of Helicobacter pylori restores rather than disturbs the gastrointestinal microbiota in asymptomatic young adults , 2019, Helicobacter.
[36] Xiaoli Ma,et al. Discovery and validation of methylated-differentially expressed genes in Helicobacter pylori-induced gastric cancer , 2019, Cancer Gene Therapy.
[37] E. Beierle,et al. Pediatric gastric adenocarcinoma: A National Cancer Data Base review. , 2019, Journal of pediatric surgery.
[38] W. Meng,et al. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer , 2019, World journal of gastroenterology.
[39] Yuan Yuan,et al. Development and validation of a prediction rule for estimating gastric cancer risk in the Chinese high-risk population: a nationwide multicentre study , 2019, Gut.
[40] C. Mărginean,et al. The Relationship between Toll-like Receptors and Helicobacter pylori-Related Gastropathies: Still a Controversial Topic , 2019, Journal of immunology research.
[41] Mototsugu Kato,et al. Serum Pepsinogen Values in Japanese Junior High School Students With Reference to Helicobacter Pylori Infection , 2019, Journal of epidemiology.
[42] Huanbai Xu,et al. LPS-induced CXCR7 expression promotes gastric Cancer proliferation and migration via the TLR4/MD-2 pathway , 2019, Diagnostic Pathology.
[43] M. Capurro,et al. VacA promotes CagA accumulation in gastric epithelial cells during Helicobacter pylori infection , 2019, Scientific Reports.
[44] Mototsugu Kato,et al. Gastric cancer in children and adolescents in Japan , 2019, Pediatrics international : official journal of the Japan Pediatric Society.
[45] Y. Xiong,et al. Analysis of culturable microbiota present in the stomach of children with gastric symptoms , 2018, Brazilian Journal of Microbiology.
[46] Mai Kusakari,et al. Clinical features of Helicobacter pylori antibody‐positive junior high school students in Nagano Prefecture, Japan , 2018, Helicobacter.
[47] Zhijun Luo,et al. Helicobacter pylori CagA promotes epithelial mesenchymal transition in gastric carcinogenesis via triggering oncogenic YAP pathway , 2018, Journal of Experimental & Clinical Cancer Research.
[48] F. Arenas-Huertero,et al. Differential expression of miRNA-146a and miRNA-155 in gastritis induced by Helicobacter pylori infection in paediatric patients, adults, and an animal model , 2018, BMC Infectious Diseases.
[49] A. Jemal,et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.
[50] Z. Herceg,et al. Genome‐wide profiling of normal gastric mucosa identifies Helicobacter pylori‐ and cancer‐associated DNA methylome changes , 2018, International journal of cancer.
[51] W. El-Rifai,et al. Helicobacter pylori‐induced miR‐135b‐5p promotes cisplatin resistance in gastric cancer , 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[52] Shan Xu,et al. MicroRNA-125a-5p inhibits invasion and metastasis of gastric cancer cells by targeting BRMS1 expression. , 2018, Oncology letters.
[53] J. L. Costa,et al. Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota , 2017, Gut.
[54] J. Korlach,et al. Genome and Methylome Variation in Helicobacter pylori With a cag Pathogenicity Island During Early Stages of Human Infection. , 2017, Gastroenterology.
[55] Ryan M. O’Connell,et al. Antitumor immunity is defective in T cell–specific microRNA-155–deficient mice and is rescued by immune checkpoint blockade , 2017, The Journal of Biological Chemistry.
[56] A. Lagomarcino,et al. Review: Prevalence and dynamics of Helicobacter pylori infection during childhood , 2017, Helicobacter.
[57] R. Bostick,et al. A Serological Biopsy Using Five Stomach-Specific Circulating Biomarkers for Gastric Cancer Risk Assessment: A Multi-Phase Study , 2017, American Journal of Gastroenterology.
[58] Yong Xie,et al. Overexpression of Tim-3 reduces Helicobacter pylori-associated inflammation through TLR4/NFκB signaling in vitro. , 2017, Molecular medicine reports.
[59] P. Sham,et al. Alterations in Gastric Microbiota After H. Pylori Eradication and in Different Histological Stages of Gastric Carcinogenesis , 2017, Scientific Reports.
[60] F. Wang,et al. MicroRNA-143-3p, up-regulated in H. pylori-positive gastric cancer, suppresses tumor growth, migration and invasion by directly targeting AKT2 , 2017, Oncotarget.
[61] B. Marshall,et al. Lipopolysaccharide Structure and Biosynthesis in Helicobacter pylori , 2016, Helicobacter.
[62] Fumie 文恵 Ikeda 池田,et al. Combination of Helicobacter pylori Antibody and Serum Pepsinogen as a Good Predictive Tool of Gastric Cancer Incidence: 20-Year Prospective Data From the Hisayama Study , 2016, Journal of epidemiology.
[63] D. Graham,et al. Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis. , 2016, Gastroenterology.
[64] Sumio Watanabe,et al. Comparison of Gene Expression Between Pediatric and Adult Gastric Mucosa with Helicobacter pylori Infection , 2016, Helicobacter.
[65] Wei Liu,et al. Association of TLR4 and Treg in Helicobacter pylori Colonization and Inflammation in Mice , 2016, PloS one.
[66] A. Califano,et al. High-definition CpG methylation of novel genes in gastric carcinogenesis identified by next-generation sequencing , 2016, Modern Pathology.
[67] K. Rudnicka,et al. Immunoregulation of antigen presenting and secretory functions of monocytic cells by Helicobacter pylori antigens in relation to impairment of lymphocyte expansion. , 2015, Acta Biochimica Polonica.
[68] N. Kaakoush,et al. Dual role of Helicobacter and Campylobacter species in IBD: a systematic review and meta-analysis , 2015, Gut.
[69] Lei Ding,et al. Dysregulation of non-coding RNAs in gastric cancer. , 2015, World journal of gastroenterology.
[70] I. Meza,et al. Helicobacter pylori CagA Suppresses Apoptosis through Activation of AKT in a Nontransformed Epithelial Cell Model of Glandular Acini Formation , 2015, BioMed research international.
[71] T. Akamatsu,et al. Screening to Identify and Eradicate Helicobacter pylori Infection in Teenagers in Japan. , 2015, Gastroenterology clinics of North America.
[72] T. Pieber,et al. Effects of high doses of vitamin D3 on mucosa-associated gut microbiome vary between regions of the human gastrointestinal tract , 2015, European Journal of Nutrition.
[73] O. Ramilo,et al. Persistent and transient Helicobacter pylori infections in early childhood. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[74] P. Malfertheiner,et al. Somatic DNA Hypomethylation in H. pylori-Associated High-Risk Gastritis and Gastric Cancer: Enhanced Somatic Hypomethylation Associates with Advanced Stage Cancer , 2015, Clinical and Translational Gastroenterology.
[75] Hisao Tajiri,et al. Plasma insulin, C‐peptide and blood glucose and the risk of gastric cancer: The Japan Public Health Center‐based prospective study , 2015, International journal of cancer.
[76] Jeffrey L. Curtis,et al. Analysis of the Upper Respiratory Tract Microbiotas as the Source of the Lung and Gastric Microbiotas in Healthy Individuals , 2015, mBio.
[77] A. Moran,et al. Helicobacter pylori-driven modulation of NK cell expansion, intracellular cytokine expression and cytotoxic activity , 2015, Innate immunity.
[78] M. Plummer,et al. Global burden of gastric cancer attributable to Helicobacter pylori , 2015, International journal of cancer.
[79] D. Queiroz,et al. CagA phosphorylation EPIYA-C motifs and the vacA i genotype in Helicobacter pylori strains of asymptomatic children from a high-risk gastric cancer area in northeastern Brazil , 2014, Memorias do Instituto Oswaldo Cruz.
[80] K. Goh,et al. Genetic polymorphisms in the Toll-like receptor signalling pathway in Helicobacter pylori infection and related gastric cancer. , 2014, Human immunology.
[81] T. Shimosegawa,et al. Novel role of toll-like receptors in Helicobacter pylori - induced gastric malignancy. , 2014, World journal of gastroenterology.
[82] C. Staedel,et al. MicroRNAs and bacterial infection , 2013, Cellular microbiology.
[83] M. Ribeiro,et al. Methylation Pattern of THBS1, GATA-4, and HIC1 in Pediatric and Adult Patients Infected with Helicobacter pylori , 2013, Digestive Diseases and Sciences.
[84] P. Correa. Gastric cancer: overview. , 2013, Gastroenterology clinics of North America.
[85] P. Stattin,et al. Prospective cohort study of metabolic risk factors and gastric adenocarcinoma risk in the Metabolic Syndrome and Cancer Project (Me-Can) , 2012, Cancer Causes & Control.
[86] A. Montserrat,et al. microRNA profiling in duodenal ulcer disease caused by Helicobacter pylori infection in a Western population. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[87] P. Massari,et al. The Role of TLR2 in Infection and Immunity , 2012, Front. Immun..
[88] M. Piazuelo,et al. The gastric precancerous cascade , 2012, Journal of digestive diseases.
[89] T. Hirayama,et al. Interweaving MicroRNAs and Proinflammatory Cytokines in Gastric Mucosa with Reference to H. pylori Infection , 2011, Journal of Clinical Immunology.
[90] Howard C. Tenenbaum,et al. Bacterial biogeography of the human digestive tract , 2011, Scientific reports.
[91] T. Meyer,et al. MicroRNA-155 Is Essential for the T Cell-Mediated Control of Helicobacter pylori Infection and for the Induction of Chronic Gastritis and Colitis , 2011, The Journal of Immunology.
[92] S. Akira,et al. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. , 2011, Immunity.
[93] T. Hirayama,et al. MicroRNA signatures in Helicobacter pylori‐infected gastric mucosa , 2011, International journal of cancer.
[94] M. Blaser,et al. Serum Pepsinogens and Helicobacter pylori in Relation to the Risk of Esophageal Squamous Cell Carcinoma in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study , 2010, Cancer Epidemiology, Biomarkers & Prevention.
[95] R. Peek,et al. Role of innate immunity in Helicobacter pylori-induced gastric malignancy. , 2010, Physiological reviews.
[96] J. Goldberg,et al. Helicobacter pylori infection, oncogenic pathways and epigenetic mechanisms in gastric carcinogenesis. , 2010, Future oncology.
[97] M. Rehli,et al. Helicobacter pylori Lipopolysaccharides Upregulate Toll-Like Receptor 4 Expression and Proliferation of Gastric Epithelial Cells via the MEK1/2-ERK1/2 Mitogen-Activated Protein Kinase Pathway , 2009, Infection and Immunity.
[98] M. Plebani,et al. GastroPanel: evaluation of the usefulness in the diagnosis of gastro-duodenal mucosal alterations in children. , 2009, Clinica chimica acta; international journal of clinical chemistry.
[99] N. Van Rooijen,et al. Macrophages Are Mediators of Gastritis in Acute Helicobacter pylori Infection in C57BL/6 Mice , 2008, Infection and Immunity.
[100] M. Kubo,et al. Impact of serum total cholesterol on the incidence of gastric cancer in a population‐based prospective study: The Hisayama study , 2008, International journal of cancer.
[101] G. Cavestro,et al. Usefulness of a Serological Panel Test in the Assessment of Gastritis in Symptomatic Children , 2007, Digestive Diseases.
[102] M. Oleastro,et al. Relationship among serum pepsinogens, serum gastrin, gastric mucosal histology and H. pylori virulence factors in a paediatric population , 2006, Scandinavian journal of gastroenterology.
[103] H. Müller-Hermelink,et al. Toll-like receptors TLR4, TLR5 and TLR9 on gastric carcinoma cells: an implication for interaction with Helicobacter pylori. , 2005, International journal of medical microbiology : IJMM.
[104] J. Goldberg,et al. Toll‐like Receptor 2‐Mediated Gene Expression in Epithelial Cells During Helicobacter pylori Infection , 2005, Helicobacter.
[105] Mark S. Sundrud,et al. Inhibition of primary human T cell proliferation by Helicobacter pylori vacuolating toxin (VacA) is independent of VacA effects on IL-2 secretion. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[106] M. D’Elios,et al. The Helicobacter pylori Vacuolating Toxin Inhibits T Cell Activation by Two Independent Mechanisms , 2003, The Journal of experimental medicine.
[107] R. Hunt,et al. Meta-analysis of the relationship between cagA seropositivity and gastric cancer. , 2003, Gastroenterology.
[108] R. Gillitzer,et al. CXC chemokines Groα/IL‐8 and IP‐10/MIG in Helicobacter pylori gastritis , 2000 .
[109] A. Terano,et al. Redox Regulation of Interleukin-8 Expression in MKN28 Cells , 1999, Digestive Diseases and Sciences.
[110] M F Dixon,et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. , 1996, The American journal of surgical pathology.
[111] M. Blaser,et al. Mosaicism in Vacuolating Cytotoxin Alleles of Helicobacter pylori , 1995, The Journal of Biological Chemistry.
[112] M. Blaser,et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. , 1995, Cancer research.
[113] A. Reunanen,et al. Body iron stores and risk of cancer , 1994, International journal of cancer.
[114] P. Correa,et al. Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. , 1992, Cancer research.
[115] Xia Zhang,et al. The correlation of the miR-29a/MMP9 axis with Helicobacter pylori infection in gastric cancer. , 2021, American journal of translational research.
[116] R. Peek,et al. DNA Transfer and Toll-like Receptor Modulation by Helicobacter pylori. , 2017, Current topics in microbiology and immunology.
[117] K. Syrjänen,et al. Stomach-specific Biomarkers (GastroPanel) Can Predict the Development of Gastric Cancer in a Caucasian Population: A Longitudinal Nested Case-Control Study in Siberia. , 2016, Anticancer research.
[118] R. Peek,et al. Pathobiology of Helicobacter pylori-Induced Gastric Cancer. , 2016, Gastroenterology.
[119] M. Gubina,et al. The immune response to Helicobacter pylori. , 2014 .
[120] S. Çam,et al. Risk of gastric cancer in children with Helicobacter pylori infection. , 2014, Asian Pacific journal of cancer prevention : APJCP.
[121] T. Wang,et al. Lack of commensal flora in Helicobacter pylori-infected INS-GAS mice reduces gastritis and delays intraepithelial neoplasia. , 2011, Gastroenterology.